$RJFBullishMed

What Are Wall Street Analysts' Target Price for Raymond James Stock?

Raymond James Financial (RJF), with a $29.5B market cap, has lagged the S&P 500 over the past year and in 2026, though its shares are up 3.4% over 52 weeks and down 5.6% YTD. For FY ending Sept. 2026, analysts expect diluted EPS of $11.83 (+11% YoY). Among 15 analysts, consensus is “Moderate Buy” (5 Strong Buy, 10 Hold). Morgan Stanley raised its target to $172; mean target is $173.92 and Street-high $198.

Med
Bullish
Dividend payable July 15, 2026; analyst-target discussion is immediate but not a fresh fundamental event.
Moderate Buy consensus with 5 Strong Buys supports a constructive tape, though not unanimous.

Street sentiment is modestly positive for RJF via dividend support and a small upward target revision tied to revenue/NII assumptions.

Raymond James (RJF) received a dividend approval and an analyst price-target raise citing higher investment banking revenue and net interest income expectations.

Near-term bias to mild upside or support on any pullbacks, but limited catalyst strength since the piece is primarily analyst-target aggregation.

Background

The article summarizes Wall Street’s target-price landscape for Raymond James and references a recent dividend approval and a prior Morgan Stanley target increase.

Why it matters

For traders, the actionable signal is sentiment calibration (Moderate Buy) plus incremental estimate/target lift tied to investment banking revenue and net interest income expectations; the dividend provides a modest near-term support narrative.

Market relevance

This is a sentiment/target update with a small fundamental rationale (IB revenue and NII expectations) and a dividend catalyst that previously coincided with a modest stock reaction.

Market effects

Supports the view that diversified broker-dealers may benefit from improving investment banking and interest-rate-linked net interest income assumptions.

Primarily US financials sentiment; no specific Canada/UK catalyst identified beyond the company’s footprint.

Limited global spillover; story is analyst-driven for a single US financial name.

Alternative perspectives

Analyst target changes may already be priced in; dividend and estimate tweaks do not guarantee execution in investment banking or NII.

Earnings surprise history is mixed (3/4 beats, 1 miss), so investors may discount targets if macro conditions or deal activity weaken.

Key entities

  • Raymond James Financial, Inc.

    Diversified financial services firm; subject of analyst target-price and dividend updates in the article.

  • Morgan Stanley

    Raised its RJF price target to $172 from $171 and increased 2026/2027 EPS estimates.

Related articles

$TCBIOMed

Texas Capital Bancshares stock hits 52-week high at 20.95 USD

Texas Capital Bancshares (TCBIO) stock recently reached a 52-week high of $20.95, reflecting strong investor confidence and a 11.12% total return over the past year. The company boasts a market capitalization of $4.34 billion, a P/E ratio of 13.23, and an attractive dividend yield of 6.86%, with InvestingPro analysis suggesting it may still be undervalued. This performance comes despite broader concerns within the banking sector regarding private credit exposure and NDFI loans, highlighted by Raymond James.

$RJFMed

Raymond James: $112 Million Advisor Larry Rolland Joins First Farmers Investment Group

Raymond James's Financial Institutions Division (FID) has welcomed financial advisor Larry Rolland, CFP, to First Farmers Investment Group (FFIG) at First Farmers Bank & Trust. Rolland, who manages over $112 million in client assets and was previously with LPL Financial, will provide investment and wealth management services. This addition reflects the continued growth of the bank-based investment program, with Rolland bringing over 25 years of experience to FFIG's Kokomo, Indiana, office.

$RJFMed

Cumberland Partners Ltd Has $4.67 Million Stock Position in Raymond James Financial, Inc. $RJF

Cumberland Partners Ltd increased its stake in Raymond James Financial (NYSE:RJF) by 56.5% in the fourth quarter, bringing their total holdings to 29,100 shares valued at approximately $4.67 million. Raymond James Financial reported better-than-expected quarterly earnings of $2.83 per share, though revenue slightly missed estimates but still grew 13.4% year-over-year. The company also declared a quarterly dividend of $0.54 per share.

$RJFMed

Raymond James: $268 Million Advisor Reece Nichols Joins Independent Channel In Texas

Financial advisor Reece Nichols, who previously managed $268 million in client assets at Edward Jones, has joined Raymond James Financial Services (RJFS). Nichols will operate as Element Financial Services in Kilgore, Texas, providing financial strategies to various client types. He highlighted Raymond James's technology, support for private wealth clients, and strong emphasis on succession planning and business ownership as key reasons for his move.